From the press resease this morning Patterson said
Post# of 148279
(Total Views: 641)
Posted On: 09/15/2020 9:32:36 AM
Re: nicehedges #55861
From the press resease this morning Patterson said
We are pleased to get these solutions out prior to the approval of Cytokine Storm-related therapeutics, and in the short term, are focused on helping those COVID-19 patients still suffering symptoms long after diagnosis—so called long-haulers. To that effort, we will be establishing a COVID-19 long-hauler diagnosis and treatment initiative involving a multi-disciplinary approach to improving the lives of those suffering long-term symptoms."
I hope this is LL - what a great partnership that would be.
IMO
We are pleased to get these solutions out prior to the approval of Cytokine Storm-related therapeutics, and in the short term, are focused on helping those COVID-19 patients still suffering symptoms long after diagnosis—so called long-haulers. To that effort, we will be establishing a COVID-19 long-hauler diagnosis and treatment initiative involving a multi-disciplinary approach to improving the lives of those suffering long-term symptoms."
I hope this is LL - what a great partnership that would be.
IMO
(3)
(0)CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼